Member Info for PrivateRyan

I recall in the very first pilot Tom did give some preliminary information on how it was going and the cost benefits - It would be nice to see some kind of update .

I suspect the interest is because the cdc pilot was originally stated to end on 31 march . That said I have my doubts about whether it is on track- Tom said they were just starting to put patients through in his last video on 10 feb ,and also that cdc commentary recently posted does seem to say it is still early days . It might be taking longet they thought to pull all the systems together. Elartu may have a view on that.
It is good to see people generally waiting it out patiently in spite of the share price fall-and little whingeing ! I hold .....

barclays have acquired a financial instrument ,not the shares . Maybe a call option or a repo. Still good news I would say .

how do you know? 4 posts?charlatan ramper maybe?

Paul said in the last video that the market doesn't yet believe his projections for growth . When that happens and it does believe he expects a rerate. Nearly there ........I hope- I have too much tied up here really

hi bennster. I think on reflection I will vote against also. I am happy to vote for on the basis of a specific acquisition proposal and see no reason why that cannot be put to the shareholders as and when a target is identified. A carte blanche is a risk to us all.

anyone notice the primary study completion date?december 2025 . and thats just phase 1 ?
I hope there is an earlier catalyst for share price improvement.!

no

Rubbish I am afraid. You cannot research this .It is just speculation. Do all the work you like but that will not give you a clue as to the timing .

satire,3.14,satire. Ridiculing CJ s statement in her style.

clues are all there- wait till october!

As with brh bennster

quote from a similar article on that site from october 21 .Just a reminder. I hope we are still on track ,or at least get a preliminary feedback from Tom.

The pilot is expected to run until March 2022 and will initially focus on delivering targeted CDC pathways in specific clinical areas such as respiratory and cardiology.

i agree.have just added two slugs of 100k shares. I dont think he is making this up and you can feel his despair at the share price level.May update could be huge ....

Bennster in my view you have to read the rns as a whole,but i agree the door would be opened for an issue which is not for that purpose.Trust in TB is low so maybe this is the perceived reason for the exercise rather than a straightforward issue on acquisition of a target.

I believe you have all got it wrong- this is not a placing for the directors-it isnot even an issue of shares- it is granting the directors the ability to issue shares to the owners of a company we are going to be targeting in exchange for their ownership of the assets/shares in that company. t gives them the ability to move fast . Whether it proves to be a good use of the shares potentially issued will dpend on what we are acquiring ,which we can determine at that time ..

hI TD .That was my point really -the wording is misleading. And in relation to actual orders ,I will relisten,but I think he says that even with an order there is no minimum ie the customer can pull out or draw down less than he anticipated.So that would explain how there always seems to be a shortfall against the expectations raised.
I missed th first 5 mins or so so will listen again ,but my general imprssion was that it was not impressive and a tad evasive.I asked a question about current market share ,and how they expected this to change so we will see how he deals with that in the written replies.
I notice also they didnt appear in person on a video - we couldnt see the sweat on the brow - though there was a lot of coughing!
As indicated before I have retained a token 100,000 shares just in case I am wrong .

so the sales pipeline number is a guess........

Article on i on I phone news about a cancer trial
In nhs. Dare we think we might piggy back ?

Paul has gone full tonto !